Særlige patientpopulationer Der er ikke observeret forskelligheder i sikkerhed eller effekt mellem ældre (≥ 65 år) patienter og yngre patienter.
4 Special patient populations No differences in safety or efficacy were observed between elderly (≥ 65 years) patients and younger patients.